Compugen Taps Porter Novelli Life Sciences
Charting the future of public relations
Holmes Report
CEO

Compugen Taps Porter Novelli Life Sciences

Drug research company Compugen has retained Porter Novelli Life Sciences to create and execute an investor and public relations campaign designed to achieve greater recognition of Compugen’s commercial progress.

Paul Holmes

TEL AVIV—Drug research company Compugen has retained Porter Novelli Life Sciences to create and execute an investor and public relations campaign designed to achieve greater recognition of Compugen’s commercial progress and drug and diagnostic discovery capabilities among the U.S. financial and media communities.

 

According to Compugen president and CEO Alex Kotzer. “As we continue to leverage our unique R&D capabilities through additional platforms, product candidates and collaborations, it’s important for Compugen to increase its visibility within the

View Style:

Load 3 More
comments powered by Disqus